The need to accelerate access to new drugs for multidrug-resistant tuberculosis

AbstractApproximately half a million people are thought to develop multidrug-resistant tuberculosis annually. Barely 20% of these people currently receive recommended treatment and only about 10% are successfully treated. Poor access to treatment is probably driving the current epidemic, via ongoing...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Helen S Cox (Egilea), Jennifer J Furin (Egilea), Carole D Mitnick (Egilea), Colleen Daniels (Egilea), Vivian Cox (Egilea), Eric Goemaere (Egilea)
Formatua: Liburua
Argitaratua: The World Health Organization, 2015-07-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri